The Summary
In the 24-month CALERIE™ 2 randomized controlled trial, researchers investigated how caloric restriction (CR) impacts metabolic health in non-obese adults aged 21 to 50. Participants followed either an ad libitum or CR diet. The CR group showed increased high-molecular-weight adiponectin and reduced levels of harmful ceramides (C16:0, C18:0, C24:0) linked to insulin resistance. This lipid remodeling partially mediated improvements in insulin sensitivity and secretion, though effects peaked at 12 months and declined by 24 months due to metabolic adaptation.
Why this is interesting
While caloric restriction is known to boost health, we didn't fully understand how in non-obese humans. This study identifies a specific pathway: the adiponectin-ceramide axis. By showing that cutting calories lowers specific toxic fats (ceramides) that cause insulin resistance, it proves CR benefits go beyond simple weight loss. For readers, this means even modest, temporary calorie reductions can fundamentally remodel blood lipids to protect metabolic health. However, the body's eventual adaptation suggests that cycling diet strategies might be necessary for long-term benefits.